By Marcus A. Banks
In 2023, representatives of the Hematology/Oncology Pharmacists Association (HOPA) went to Capitol Hill twice (once virtually, once in person) to promote the interests of hematology and oncology pharmacists and their patients to legislators and their staff members.
This intensified work—an increase from the single annual visits that HOPA organized in prior years—comes as HOPA ramps up its lobbying efforts, speakers noted during an advocacy update session at the HOPA